Modeling Patient-Derived Glioblastoma with Cerebral Organoids
2019 · Cell Reports · 447 citations
https://doi.org/10.1016/j.celrep.2019.02.063
K
Ken Miyaguchi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
27
Papers
1.7K
Citations
12
h-index
13
i10-index
Ken Miyaguchi is an academic researcher. The author has contributed to research in topics: Glioma Diagnosis and Treatment & Cancer, Hypoxia, and Metabolism & MicroRNA in disease regulation. The author has an h-index of 12, co-authored 23 publications.
Papers by this author
worksPARVB overexpression increases cell migration capability and defines high risk for endophytic growth and metastasis in tongue squamous cell carcinoma
2014 · British Journal of Cancer · 38 citations
https://doi.org/10.1038/bjc.2014.590
Activated T cell therapy targeting glioblastoma cancer stem cells
2023 · Scientific Reports · 7 citations
https://doi.org/10.1038/s41598-022-27184-w
296 Towards Nose-to-brain Inhibition of NFB: Activity of a Novel p65 Inhibitor in Glioblastoma and Feasibility of Intranasal Delivery With a Near-infrared Fluorescent HMC-Chitosan Nanoparticle
2024 · Neurosurgery · 0 citations
https://doi.org/10.1227/neu.0000000000002809_296
235 IL-4/13 Blocking Peptide (KROS-401) Inhibits M2 Macrophage Polarization in vitro and Demonstrates Anti-tumor Activity in a Murine Model of Glioblastoma
2024 · Neurosurgery · 0 citations
https://doi.org/10.1227/neu.0000000000002809_235
511 Iron Oxide Nanoplatform HMC-FMX for Targeted Chemotherapeutic Treatment of Glioblastoma
2024 · Neurosurgery · 0 citations
https://doi.org/10.1227/neu.0000000000002809_511
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat